Angiotensin 2 Type 1 Receptor Blockade with Neprilysin Inhibition for Chronic Heart Failure: A New Paradigm?

Richards Arthur Mark

首页> 外文期刊>Annals of the Academy of Medicine, Singapore >Angiotensin 2 Type 1 Receptor Blockade with Neprilysin Inhibition for Chronic Heart Failure: A New Paradigm?

【24h】

Angiotensin 2 Type 1 Receptor Blockade with Neprilysin Inhibition for Chronic Heart Failure: A New Paradigm?

机译：血管紧张素2 1型受体阻滞剂与脑啡肽酶抑制剂对慢性心力衰竭的抑制作用：一种新的范式？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of the Academy of Medicine, Singapore》 |2015年第8期|共2页
作者
Richards Arthur Mark;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词

相似文献

外文文献
中文文献
专利

1. Angiotensin 2 Type 1 Receptor Blockade with Neprilysin Inhibition for Chronic Heart Failure: A New Paradigm? [J] . Richards Arthur Mark Annals of the Academy of Medicine, Singapore . 2015,第8期

机译：血管紧张素2 1型受体阻滞剂与脑啡肽酶抑制剂对慢性心力衰竭的抑制作用：一种新的范式？
2. Dual Angiotensin Receptor and Neprilysin Inhibition with Sacubitril/Valsartan in Chronic Systolic Heart Failure: Understanding the New PARADIGM [J] . Lillyblad Matthew P. The annals of pharmacotherapy . 2015,第11期

机译：倍他乐克/缬沙坦对慢性收缩性心力衰竭的双重血管紧张素受体和中性溶酶抑制作用：了解新的PARADIGM
3. Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial [J] . Packer Milton, Claggett Brian, Lefkowitz Martin P., The lancet. Diabetes & endocrinology. . 2018,第7期

机译：内芳素抑制对2型糖尿病患者肾功能的影响，患有肾素 - 血管紧张素系统抑制剂靶剂量的患者：帕拉维-HF试验的二级分析
4. Attenuation of Myocardial Stunning by Angiotensin II Type 1 Receptor Blockade with Candesartan: Role of the Type 2 Receptor [C] . B.I. Jugdutt, V. Mcnon International Congress on Coronary Artery Disease . 2003

机译：血管紧张素II型1受体封闭因子的抗心肌壮丽的衰减：2型受体的作用
5. Reversal of Cardiac and Subcellular Remodeling in Congestive Heart Failure by Blockade of Catecholamine and Angiotensin Receptors [D] . Babick, Andrea Petrusia 2010

机译：通过阻滞儿茶胺和血管紧张素受体逆转心血和亚细胞重塑的心脏和亚细胞重塑
6. Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF) [O] . John J. V. McMurray, Milton Packer, Akshay S. Desai, -1

机译：在慢性收缩性心力衰竭患者中双重血管紧张素受体和中性溶酶抑制作用可替代血管紧张素转换酶抑制作用：ARNI与ACEI的前瞻性比较的原理和设计以确定在心衰试验中对全球死亡率和发病率的影响（PARADIGM- HF）
7. Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF). [O] . McMurray John J V, Packer Milton, Desai Akshay S, 2013

机译：在慢性收缩性心力衰竭患者中，双重血管紧张素受体和中性溶酶抑制作用可替代血管紧张素转换酶抑制作用：ARNI与ACEI的前瞻性比较的原理和设计，以确定在心衰试验中对全球死亡率和发病率的影响（PARADIGM- HF）。

Angiotensin 2 Type 1 Receptor Blockade with Neprilysin Inhibition for Chronic Heart Failure: A New Paradigm?

著录项

相似文献

相关主题

期刊订阅